Publications by authors named "Ina R Vogt"

Claim this Profile
G
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).
Sabrina Katzdobler, Georg Nübling, Martin Klietz, Urban M Fietzek, Carla Palleis, Ina R Vogt

J Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perivascular space enlargement accelerates in ageing and Alzheimer's disease pathology: evidence from a three-year longitudinal multicentre study.
Inga Menze, Jose Bernal, Pinar Kaya, Çağla Aki, Malte Pfister, Ina R Vogt

Alzheimers Res Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.
Hannah Baumeister, Jacob W Vogel, Philip S Insel, Luca Kleineidam, Steffen Wolfsgruber, Ina R Vogt

Brain· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS.
Madhurima Chatterjee, Selcuk Özdemir, Christian Fritz, Wiebke Möbius, Luca Kleineidam, Ina R Vogt

Nat Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline.
Melina Stark, Steffen Wolfsgruber, Luca Kleineidam, Ingo Frommann, Slawek Altenstein, Ina R Vogt

Neurology· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scale for the assessment and rating of ataxia: Age-dependent performance of healthy adults.
Marcus Grobe-Einsler, Alina Schmidt, Tamara Schaprian, Ina R Vogt, Thomas Klockgether

Eur J Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Gait Biomarkers Allow to Capture 1-Year Longitudinal Change in Spinocerebellar Ataxia Type 3.
Winfried Ilg, Björn Müller, Jennifer Faber, Judith van Gaalen, Holger Hengel, Ina R Vogt

Mov Disord· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Rivastigmine on Patients with Spinocerebellar Ataxia Type 3: A Case Series of Five Patients.
Marcus Grobe-Einsler, Ina Rosemarie Vogt, Tamara Schaprian, Rene Hurlemann, Thomas Klockgether

Neurodegener Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
Ina R Vogt, Andrew J Lees, Bernd O Evert, Thomas Klockgether, Michael Bonin

Exp Neurol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3.
Bernd O Evert, Ina R Vogt, Ana M Vieira-Saecker, Lucia Ozimek, Rob A I de Vos

J Neuropathol Exp Neurol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis